An adipose tissue-released hormone could play a key role in obesity-related asthma, reveals a study presented at ENDO 2019 the Endocrine Society's annual meeting in New Orleans. The finding could become a new target of future treatments for the disease.
Along with genetic susceptibility and environmental exposures, obesity is emerging as a risk factor for asthma. Many studies have shown obesity also affects the course of asthma. However, scientists do not understand how obesity contributes to asthma. An estimated 40 percent of people with asthma have obesity.
Asthma
It''s a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it
Advertisement
‘The results of the study suggest that anti-aP2 treatments hinder obesity-related asthma development and its chronic complications.’
Tweet it Now
"There is a great unmet need for novel treatments for obesity-related asthma, because these patients are less-responsive to current therapies," said lead researcher M. Furkan Burak, M.D., of the Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital in Boston, Mass.
The study looked at the adipose hormone aP2, which is increased in the circulation of humans and animals with obesity. It is involved in the body's inflammatory responses and previously has been shown to contribute to chronic inflammatory diseases associated with obesity, such as diabetes and heart disease. In previous research, the investigators detected increased aP2 levels in blood and lung fluid in mice with obesity.
![Tests for Asthma]( "Tests for Asthma")
Do you find it difficult to breathe especially during the cold weather? You may need to get tested for asthma, a respiratory condition that is induced by allergies.
In the new study, they measured aP2 levels in blood and lung fluid of people with and without asthma. They found aP2 levels were 25.4 percent higher in the blood of people who were affected by asthma and met the criteria for obesity or being overweight, compared with people without asthma. Higher levels of aP2 were associated with asthma status only in people with overweight or obesity. There was no significant difference in aP2 levels in normal-weight people with and without asthma.
They also measured aP2 levels in lung fluid collected from 13 people with obesity and 36 normal-weight people with and without asthma. They found aP2 levels from the individuals with obesity were 23 percent higher compared with the other study participants.
"These data suggest that aP2 may be an independent risk factor for obesity-related asthma," said co-investigator Gurol Tuncman, M.D. Ph.D., of the Harvard T.H. Chan School of Public Health. "The findings also suggest anti-aP2 treatments can impede obesity-related asthma development and its chronic complications. Our studies present an exciting opportunity for clinical translation of anti-aP2 drugs to treat obesity-related asthma."
Source: Eurekalert
Tests for Asthma
Do you find it difficult to breathe especially during the cold weather? You may need to get tested for asthma, a respiratory condition that is induced by allergies.
Advertisement
In the new study, they measured aP2 levels in blood and lung fluid of people with and without asthma. They found aP2 levels were 25.4 percent higher in the blood of people who were affected by asthma and met the criteria for obesity or being overweight, compared with people without asthma. Higher levels of aP2 were associated with asthma status only in people with overweight or obesity. There was no significant difference in aP2 levels in normal-weight people with and without asthma.
They also measured aP2 levels in lung fluid collected from 13 people with obesity and 36 normal-weight people with and without asthma. They found aP2 levels from the individuals with obesity were 23 percent higher compared with the other study participants.
"These data suggest that aP2 may be an independent risk factor for obesity-related asthma," said co-investigator Gurol Tuncman, M.D. Ph.D., of the Harvard T.H. Chan School of Public Health. "The findings also suggest anti-aP2 treatments can impede obesity-related asthma development and its chronic complications. Our studies present an exciting opportunity for clinical translation of anti-aP2 drugs to treat obesity-related asthma."
Source: Eurekalert
Childhood Asthma
Childhood asthma is a condition that affects airways in children and interferes with their daily activities including play, sports, school and sleep.
Advertisement
 Occupational AsthmaOccupational Asthma (OA) is a lung disorder that occurs due to exposure to toxic substances at the workplace. The mainstay of management of OA is reduction of exposure to the toxic substances. | Advertisement
|
Advertisement
Recommended Reading
Latest Obesity News
Researchers examine the role of unknown protein NOTCH2-associated receptor2 (MINAR2) in obesity and diabetes using generated Minar2 knockout (KO) mice.
Study reports that body contouring after bariatric surgery does not contribute to long-term weight loss in patients with massive weight loss.
Recently FDA-approved drug semaglutide has proven as a highly effective anti-obesity medication showcasing remarkable weight loss benefits.
Gut bacteria profile and abundance in toddlers can serve as a predictive factor for their body mass index (BMI) at age 5, irrespective of premature birth status.
Obese individuals were found to have weaker appetite regulation, with factors that inhibit eating behavior.